DANIELLE GULLETTE: Open Payments
NPI 1821764440 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,901 in 140 payments from 16 companies in 2025. Trend: 2023 $1,011 · 2024 $1,353 · 2025 $2,901
Food & beverage: $2,884Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $524 |
| GlaxoSmithKline, LLC. | 30 | $523 |
| GENZYME CORPORATION | 10 | $288 |
| Verona Pharma, Inc. | 12 | $250 |
| Insmed, Inc. | 13 | $215 |
| Viatris Specialty LLC | 10 | $202 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $196 |
| Regeneron Healthcare Solutions, Inc. | 6 | $182 |
| Grifols USA, LLC | 10 | $176 |
| Actelion Pharmaceuticals US, Inc. | 9 | $139 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, TEZSPIRE, YUPELRI, Arikayce, Prolastin-C Liquid, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
